5FA.F NIPRO CORP.

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
7.40 EUR
Close of Nov 11, 2026
7.20 9.17
Market cap
EUR 1.21B
P/E
17.2x
P/B
0.67x
ROE
5.4%
Dividend yield
2.15%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 5FA.F undervalued?

Graham number
Price7.40
Graham value10.35
Discount28.5%

5FA.F trades 28.5% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NIPRO CORP. fundamental analysis

No fundamental analysis for NIPRO CORP. yet.

NIPRO CORP. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NIPRO CORP.

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses worldwide. The company offers renal products; interventional products, such as cardiovascular products, endovascular products, and accessories; and hospital products, including hypodermic needles, syringes, IV sets and catheters, 3-way stopcocks, infusion sets, balloon infusers, etc. It also provides cardiopulmonary products comprising oxygenato…

Full company profile